Inj, bortezomib, nos, 0.1 mg
This code is not in the latest file (4Q26). It was last listed in 4Q22.
Payment limit per 0.1 MG, by effective quarter, 1Q21 to 4Q22. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9044
No NDCs mapped to this code in the 4Q26 crosswalk.
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q22 | $8.374 | −$6.492 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted June 22, 2023 |
| 3Q22 | $14.866 | −$0.793 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted June 9, 2023 |
| 2Q22 | $15.659 | −$1.112 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted December 14, 2022 |
| 1Q22 | $16.771 | −$1.536 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted June 8, 2022 |
| 4Q21 | $18.307 | −$0.996 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted June 2, 2022 |
| 3Q21 | $19.303 | −$2.299 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted June 2, 2022 |
| 2Q21 | $21.602 | +$0.501 | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted March 1, 2022 |
| 1Q21 | $21.101 | – | 0.1 MG | Inj, bortezomib, nos, 0.1 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021